Assignee
APTACURE THERAPEUTICS LTD
CN·1 granted patent·2 pending applications·0 citations·filing 2019–2022
Top patents by PatentIndex Score
3 records- 0149US2024200081A1Nucleic acid molecule conjugate having prolonged in vivo half-lifeAPTACURE THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 0248US2024401063A1Aptamer for DKK1 and Use ThereofAPTACURE THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 0343US12338441B2Aptamer for sclerostin and use thereofAPTACURE THERAPEUTICS LTD·Filed 2019·Granted Jun 24, 2025·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when APTACURE THERAPEUTICS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →